See the DrugPatentWatch profile for lipitor

Yes, Lipitor's patient assistance program does consider low income as a factor in determining eligibility for the program. The program, called the Lipitor Patient Assistance Program, is designed to help eligible patients who do not have prescription drug coverage and cannot afford Lipitor.

To be eligible for the program, patients must meet certain income guidelines. As of 2021, the program considers patients with an annual income of up to $30,350 for individuals and up to $41,150 for couples as low income. These income limits may vary from year to year.

Additionally, patients must be legal residents or citizens of the United States or its territories, and they must be prescribed Lipitor by a licensed healthcare provider for an FDA-approved indication.

It's important to note that the Lipitor Patient Assistance Program is administered by Pfizer RxPathways, which offers assistance for a range of Pfizer medications. Patients can apply for the program online or by mail, and they will need to provide information about their income, insurance coverage, and prescription medication needs.

In summary, Lipitor's patient assistance program does consider low income as a factor in determining eligibility for the program. Patients who meet the income guidelines, residency requirements, and other eligibility criteria may be able to receive Lipitor at no cost or at a reduced cost through the program.

Sources:

1. Lipitor Patient Assistance Program. Pfizer RxPathways. <https://www.pfizerrxpathways.com/programs/lipitor-patient-assistance-program>.
2. Drug Patent Watch. Lipitor (Atorvastatin) Pipeline & Patent Expiry Analysis - DrugPatentWatch. <https://drugpatentwatch.com/drugs/lipitor>.